Eighteen Platelet transfusion continues to be the mainstay of treatment for perioperative thrombocytopenia, but could be ineffective in certain populations, carry all of the risks of blood solution transfusion, and therefore are a scarce resource.19 With efficient TPO-RA therapy, individuals with recognized thrombocytopenia undergoing elective procedures could undergo pharmacologic pl... https://seridopidine93027.blogdomago.com/26277186/camostat-mesylate-an-overview